Australian Health Journal

Michelle Fenwick – Northern Health

The outskirts of Melbourne is experiencing significant population growth over the next 10 years and Northern Health has taken preemptive steps to ensure the supply of new talented healthcare staff as well as develop the culture of the workplace.

Michelle Fenwick, the Executive Director of Northern Health spoke with our reporter Anne Dao on the challenges of this urban growth over the past 3 years. By 2031 the region is expected to increase in population by 63%. Added to this is hiring and training the right workforce to align with the clinical care needs of people coming into the healthcare centres.

Culture is forming in a growing organisation with approximately 70% of staff having been at Northern Health less than 4 years. However there is opportunity for clinical staff to accelerate their career in such an environment

Medical Technology Association of Australia

The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

MTAA represents manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and management of disease and disability. The range of medical technology is diverse with products ranging from familiar items such as syringes and wound dressings, through to high-technology implanted devices such as pacemakers, defibrillators, hip and other orthopaedic implants. Products also include hospital and diagnostic imaging equipment such as ultrasounds and magnetic resonance imaging machines.

MTAA members distribute the majority of the non-pharmaceutical products used in the diagnosis and treatment of disease and disability in Australia. Our member companies also play a vital role in providing healthcare professionals with essential education and training to ensure safe and effective use of medical technology.

ARCS Australia

ARCS Australia Ltd is a national, membership-based organisation focused on the development and growth of the healthcare sector. ARCS provides education, career pathways, professional development and advocacy to the healthcare sector.

Our membership is made up of individuals working in regulatory affairs, clinical research, health economics, medical information and other disciplines who work in the development and quality use of therapeutic goods. ARCS members are based in industry, academia, medical research institutes, government, hospitals and patient groups.
Through its members ARCS has a broad and effective reach throughout the healthcare sector, and provides a neutral forum to develop, agree and implement aligned policies and initiatives.

ARCS and its members are dedicated to improving the quality of life of healthcare consumers.

Interview with Kylie Ward, CEO Australian College of Nursing

Kylie Ward, CEO Australian College of Nursing spoke with Anne Dao from Australian Health Journal, at last week’s Australian Healthcare Week Expo on the vital role of the nursing professional.

Australian College of Nursing oversees 390,000 nurses in Australia and is the national leader in the nursing profession.

Changes in nursing policy are needed in areas of aged care, chronic disease and workforce sustainability. There are forecasts of shortages in nursing by the year 2025 of 80,000 and by 2030 the number growing by 125,000.

Kylie also mentioned the new Nursing Trailbrazers Award that has been recognised by Federal Health Minister, Greg Hunt. The 4 finalists have been recognised for influencing models of care, and implementing game changing initiatives across the country. They will be presented at the Nursing Now Australia event held by the ACN on 9th April.

Australian Healthcare Week 2019: Pitch Fest Finalist Coviu

Telelheath startup company Coviu was a Pitch Fest Finalist at last week’s Australian Healthcare Week Expo in Sydney. The Coviu platform has been developed as an spinoff from CSIRO and allows healthcare businesses offer video consultations to their own patients. It differs from being just a ‘talking head’ platform that Skype or Zoom could offer, by providing clinical tools integrated within the app. Anne Dao spoke with Co-founder and CEO Silvia Pfeiffer about the company and platform’s journey to date and its longer term goals.

Coviu helps healtcare businesses by helping fit in more consultation during that day and reducing no-shows for appointments. Also given the nature of the dispersed population, the application reaches to rural and regional areas where patients are a long distance from their healthcare provider. The company is focused on the Australian market and aims to enter the US market next year

AHJ S1E1: Sydney TMS: Transcranial Magnetic Stimulation

TMS (Transcranial Magnetic Stimulation) is a mild form of brain stimulation. Magnetic fields, generated by a coil placed on the head, are used to stimulate a small area of the brain. It is a non-invasive procedure that treats the symptoms of depression through the use of magnetic fields that stimulate nerve cells. The stimulation takes 20-30 minutes and given on an outpatient basis. While receiving stimulation, the patient is fully awake.

It can be use to treat patients who have little success with common treatments e.g., medication, psycho-therapy.

Sydney TMS operates 3 clinics in Australia that provide TMS treatment to patients. Founder Dr Jason Pace spoke with Australian Health Journal

Clinical Trials in Australia

Shanny Dyer, CEO ARCS Australia talks about a recent summit where the CRO (Contract Research Organization) community was asked on the current state of clinical trials in Australia.

Episode 4 Season 1

Profiling “Inside MS” for trainee doctors understanding MRI data. 10 Year anniversary of the TAVI heart procedure. White Coats Foundation also talk about clinical trials.

AHJ S1E4: Augmented Reality Learning – Inside MS

Augmented learning now has application seeing the changes in a patient’s brain with Multiple Sclerosis through MRI data. Australian Health Journal met the people behind the augmented reality visor technology that will soon be used to teach trainee doctors the transitional phases of MS.

The technology has been developed by Novartis and in collaboration with the Sydney Neuroimaging Analysis Centre, located within the University of Sydney’s Brain and Mind Centre and Hatch Australia, a creative design team based in Sydney. To date the technology has been well received by neurology health care specialists attending conferences in Melbourne and in Berlin, Germany. We caught with a demo for all other healthcare professionals at the recent ARCS Conference.

AHJ S1E4: TAVI 10 Year Anniversary

2018 marks the 10 year anniversary of the TAVI device, short for the Transcatheter Aortic Valve Implantation. The TAVI system enables the replacement of a diseased aortic valve without open-heart surgery or surgical removal of the native valve.

This minimally invasive surgical option reduces operating time and allows for a shortened recovery period for patients.

AHJ met with the cardiologist teams in Melbourne’s Epworth and Alfred Hospital who have involved in implanting the device over the past 10 years.

Interviews:

  • Associate Professor Tony Walton, Epworth Hospital, Director of Catheter Laboratory and Deputy Director of Cardiology – Alfred Health
  • Associate Professor Ron Dick, Director of Cardiac Sciences – Epworth Healthcare
  • Professor Stephen Duffy, Alfred Health
Scroll to top